We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Celoxica | LSE:CXA | London | Ordinary Share | GB00B0L9TZ33 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.20 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:3482T Celoxica Holdings PLC 29 April 2008 CELOXICA HOLDINGS PLC ("CELOXICA", "THE COMPANY" or "THE GROUP") Trading Update, Subscription of Ordinary Shares and Notice of Meeting 29th April 2008 - The Board of Celoxica Holdings plc (AIM: CXA) - a leading provider of High Performance Computing solutions today provides the following trading update. Following the recruitment of Lee Staines in July 2007, the appointment of Jean-Marc Bouhelier as a non-executive director in October 2007 and the sale of the Electronic System Level design business in January 2008, Celoxica has repositioned itself as a provider of Accelerated Computing systems with a particular focus on high speed, low latency solutions for the financial services industry. These solutions enable trading firms, exchanges and market data vendors to redress the balance of data volumes outstripping advances in CPU speeds and help address the increasing problems of power consumption, heat generation and space constraints. The Directors are encouraged by the initial response from financial institutions. We are pleased to announce that we have secured preliminary orders totalling approximately $370,000 with two major U.S. financial institutions. These contracts will see the first integration of the Company's solution into a live trading environment and it is believed that they will mark the beginning of a long relationship with these organisations. The Directors believe that it is now in the best interests of the Company to initiate an investment programme in order to take advantage of the increasing opportunities in the financial services accelerated computing market. The Company therefore announces that it proposes to raise up to #2 million (before expenses) by way of a subscription through the issue of up to 200,000,000 Ordinary Shares at a price of 1 pence per share. The Subscription Price represents a discount of approximately 67 per cent. to the closing mid-market price of 3 pence per Existing Ordinary Share on 28 April 2008, being the last dealing day prior to this announcement. Assuming subscription in full, the Subscription Shares will represent up to approximately 70.3 per cent. of the Company's Enlarged Ordinary Share Capital. A total of 135,500,000 Subscription Shares have been conditionally subscribed for by institutional and other investors to date. Subject, inter alia, to the passing of the Resolutions at the Meeting on 23 May 2008, Admission and dealings in the Subscription Shares are expected to commence on AIM on 27 May 2008. As part of the Subscription, certain Directors are subscribing for an aggregate of 32,500,000 Subscription Shares. Certain Directors (and their related parties) and other Shareholders have irrevocably undertaken to vote in favour of the Resolutions in respect of 37,175,082 Existing Ordinary Shares, representing, in aggregate, approximately 44.1 per cent. of the Company's Existing issued Ordinary Shares. The Company intends to invest the net proceeds of the Share Subscription as follows: * to develop application specific IP and products for the accelerated computing market, focusing specifically on financial services and in particular on market data acceleration; * to enable the Company to recruit into key roles both in the UK and the US; and * to provide working capital for the Company. Lee Staines, Chief Executive, commented: "Progress to date is extremely encouraging and we need to ensure that Celoxica is well positioned to take advantage of the increasing demand for our products and services by raising sufficient funds. We would like to welcome the new investors and thank our existing shareholders for their continued support." ENQUIRIES Celoxica Holdings plc (www.celoxica.com) Tel. +44 (0)1235 863 656 Lee Staines, CEO Michelle Young, CFO ICIS Tel. +44 (0) 20 7651 8688 Tom Moriarty +44 (0) 7843 260 623 Caroline Evans-Jones Arbuthnot Tel. +44 (0) 20 7012 2000 Tom Griffiths Alasdair Younie About Celoxica Celoxica is a leader in accelerated computing solutions, with a focus on low latency solutions for Financial Services. Headquartered in Abingdon, Oxfordshire and New York, Celoxica is a public company quoted on AIM at the London Stock Exchange (AIM: CXA). Our IP lies in the unique Accelerator Card by Celoxica and our solutions combine accelerated hardware, firmware, Application Programming Interfaces (APIs) and professional services. For more information, please visit the company website at www.celoxica.com SUBSCRIPTION FOR ORDINARY SHARES, AUTHORITIES TO ISSUE SECURITIES AND NOTICE OF MEETING 1. Introduction The Company announces that it proposes to raise up to #2 million (before expenses) by way of a share subscription for up to 200,000,000 Ordinary Shares at a price of 1p per share. The net proceeds of the Share Subscription will be used to fund investment in the growth of the Company and for working capital purposes. The Firm Subscription Shares have been conditionally subscribed for by institutional and other investors. It is intended that up to a further 64,500,000 Subscription Shares will be available for subscription at the discretion of the Board. Subject, inter alia, to the passing of the Resolutions at the Meeting, Admission and dealings in the Subscription Shares are expected to commence on AIM on 27 May 2008 The Share Subscription is conditional, inter alia, upon the Company obtaining approval from Shareholders at the Meeting. Certain Directors (and their related parties) and other Shareholders have irrevocably undertaken to vote in favour of the Resolutions in respect of 37,175,082 Existing Ordinary Shares, representing, in aggregate, approximately 44.1 per cent. of the Company's Existing Ordinary Shares. 2. Background to and reasons for the Share Subscription Celoxica has repositioned itself in the accelerated computing ("AC") market and provides high speed, low latency solutions to the financial services industry. These solutions enable trading firms, exchanges and market data vendors to redress the balance of data volumes outstripping advances in CPU speeds and help address the increasing problems of power consumption, heat generation and space constraints. The Company sold its Electronic System Level (ESL) business in January 2008 and raised US $3 million gross. The Directors believe that completion of this sale has enabled the Company to focus on the launch and implementation of its Market Data Accelerator product line and further execution of its financial services accelerated computing business plan. Progress so far in 2008 includes two preliminary orders totalling approximately $370,000 from a US Stock Exchange and a Chicago-based proprietary trading firm. The Directors believe that it is in the best interests of the Company to initiate an investment programme in order to take advantage of the increasing opportunities in the financial services accelerated computing market. For this purpose the Company requires increased investment which the Share Subscription will provide. The Company intends to invest the net proceeds of the Share Subscription as follows: * to develop application specific IP and products for the accelerated computing market, focusing specifically on financial services and in particular on market data acceleration; * to enable the Company to recruit into key roles both in the UK and the US; and * to provide working capital for the Company. 3. Details of the Share Subscription The Company proposes to raise up to #2 million (before expenses) through the issue of the Subscription Shares at the Subscription Price. The Subscription Price represents a discount of approximately 67 per cent. to the closing mid-market price of 3 pence per Existing Ordinary Share on 28 April 2008, being the last dealing day prior to this announcement. Firm commitments to subscribe for a total of 135,500,000 Ordinary Shares have been received by the Company. Up to a further 64,500,000 Subscription Shares will be available for subscription at the discretion of the Board. Assuming subscription in full, the Subscription Shares will represent approximately 70.3 per cent. of the Company's Enlarged Ordinary Share Capital. Application has been made to the London Stock Exchange for the Subscription Shares to be admitted to trading on AIM. It is expected that Admission will become effective and that dealings in the Subscription Shares on AIM will commence on 27 May 2008. The Subscription Shares will rank pari passu in all respects with the Existing Ordinary Shares, including the right to receive all dividends and other distributions declared following Admission. As part of the Share Subscription, certain of the Directors have agreed to subscribe for 32,500,000 Subscription Shares in aggregate at the Subscription Price. This represents approximately 16.3 per cent. of the maximum number of Subscription Shares. Under the Share Subscription, Lee Staines has agreed to subscribe for 7,500,000 Subscription Shares, David Cheesman has agreed to subscribe for 5,000,000 Subscription Shares, Jean-Marc Bouhelier has agreed to subscribe for 15,000,000 Subscription Shares and Jack Fryer has agreed to subscribe for 5,000,000 Subscription Shares, all at the Subscription Price. On completion of the Share Subscription, Lee Staines will hold 7,710,526 Ordinary Shares, representing approximately 2.7 per cent. of the maximum Enlarged Ordinary Share Capital, David Cheesman will hold 5,360,000 Ordinary Shares, representing approximately 1.9 per cent. of the maximum Enlarged Ordinary Share Capital, Jean-Marc Bouhelier will hold 17,105,263 Ordinary Shares, representing approximately 6 per cent. of the maximum Enlarged Ordinary Share Capital and Jack Fryer will hold 5,695,743 Ordinary Shares, representing approximately 2 per cent. of the maximum Enlarged Ordinary Share Capital. 4. Undertakings to Vote Each of the Directors who currently hold Ordinary Shares and certain other shareholders have irrevocably undertaken to the Company to vote (or to procure the voting) in favour of the Resolutions at the Meeting. 5. Meeting The Meeting will be held on 23 May 2008 at the offices of the Company at 66 Milton Park, Abingdon, Oxfordshire OX14 4RX at 10.00 a.m. at which the Resolutions will be proposed to permit the issue of the Subscription Shares. DEFINITIONS The following definitions apply throughout this document, unless the context requires otherwise: "Admission" the admission of the Subscription Shares to trading on AIM becoming effective in accordance with the AIM Rules "AIM" the market of that name operated by the London Stock Exchange "AIM Rules" the rules of AIM governing admission to and the operation of AIM for AIM companies and their nominated advisers as published by the London Stock Exchange from time to time "Company" or "Celoxica" Celoxica Holdings plc "Directors" or "Board" directors of the Company "Enlarged Ordinary Share Capital" up to 284,307,435 Ordinary Shares (including the maximum number of Subscription Shares) in issue immediately following Admission "Existing Ordinary Shares" the 84,307,435 Ordinary Shares in issue at the date of this document "Firm Subscription Shares" the 135,500,000 Subscription Shares in respect of which binding agreements to subscribe have been received by the Company as at the date of this document "London Stock Exchange" London Stock Exchange plc "Meeting" the extraordinary general meeting of the Company's Shareholders convened for 10.00 a.m. on 23 May 2008, notice of which is set out at the end of this document "Meeting Notice" the notice convening the Meeting "Ordinary Shares" ordinary shares in the capital of the Company having a nominal value of 1 pence "Resolutions" the resolutions as set out at the Meeting "Shareholders" holders of Ordinary Shares "Share Subscription" the subscription for the Subscription Shares on the terms set out in this circular "Subscription Price" 1 pence per Subscription Share "Subscription Shares" up to 200,000,000 new Ordinary Shares to be issued pursuant to the Share Subscription "United Kingdom" or "UK" the United Kingdom of Great Britain and Northern Ireland "United States" or "US" the United States of America, its territories, possessions and domains END This information is provided by RNS The company news service from the London Stock Exchange END IOEFKCKKNBKDBQB
1 Year Celoxica Chart |
1 Month Celoxica Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions